Serveur d'exploration Tocilizumab - Analysis (2020)

Index « Titre (en) » - entrée « rheumatic »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
reward < rheumatic < rheumatica  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000006 (2020) Anna Jakubczyc ; Claus Neurohr[Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
000099 (2020) Carlo Perricone [Italie] ; Paola Triggianese [Italie] ; Elena Bartoloni [Italie] ; Giacomo Cafaro [Italie] ; Angelo F. Bonifacio [Italie] ; Roberto Bursi [Italie] ; Roberto Perricone [Italie] ; Roberto Gerli [Italie]The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
000126 (2020) E C Schwaneck [Allemagne] ; R. Renner [Allemagne] ; L. Junker [Allemagne] ; H-P Tony [Allemagne] ; S. Kleinert [Allemagne] ; M. Gernert [Allemagne] ; M. Schmalzing [Allemagne] ; O. Gadeholt [Allemagne]T cells, natural killer cells, and γδT cells in a large patient cohort with rheumatoid arthritis: influence of age and anti-rheumatic therapy.
000146 (2020) Francis F. Furia [Tanzanie] ; Evance Godfrey [Tanzanie] ; Naomi Mwamanenge [Tanzanie] ; Peter Swai [Tanzanie]Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania
000166 (2020) Elyes Bouajina [Tunisie] ; Leith Zakraoui [Tunisie] ; Montassar Kchir [Tunisie] ; Samir Kochbati [Tunisie] ; Sofiene Baklouti [Tunisie]Safety and efficacy of tocilizumab as monotherapy or in combination with methotrexate in Tunisian patients with active rheumatoid arthritis and inadequate response to disease-modifying anti-rheumatic drugs in conditions close to clinical practice.
000188 (2020) Milena A. Gianfrancesco [États-Unis] ; Kimme L. Hyrich [Royaume-Uni] ; Laure Gossec [France] ; Anja Strangfeld [Allemagne] ; Loreto Carmona [Espagne] ; Elsa F. Mateus [Portugal, Suisse] ; Paul Sufka [États-Unis] ; Rebecca Grainger [Nouvelle-Zélande] ; Zachary Wallace [États-Unis] ; Suleman Bhana [États-Unis] ; Emily Sirotich [Canada] ; Jean Liew [États-Unis] ; Jonathan S. Hausmann [États-Unis] ; Wendy Costello [Irlande (pays)] ; Philip Robinson [Australie] ; Pedro M. Machado [Royaume-Uni] ; Jinoos Yazdany [États-Unis]Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries
000197 (2020) Angela Ceribelli [Italie] ; Francesca Motta [Italie] ; Maria De Santis [Italie] ; Aftab A. Ansari [États-Unis] ; William M. Ridgway [États-Unis] ; M. Eric Gershwin [États-Unis] ; Carlo Selmi [Italie]Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
000206 (2020) Christos Koutsianas ; Konstantinos Thomas ; Dimitrios VassilopoulosReactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
000296 (2020) Mayan Gilboa [Israël] ; Gil Bornstein [Israël] ; Ilan Ben-Zvi [Israël] ; Chagai Grossman [Israël]Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review.
000336 (2020) Christophe Richez [France] ; Estibaliz Lazaro [France] ; Maël Lemoine [France] ; Marie-Elise Truchetet [France] ; Thierry Schaeverbeke [France]Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases
000356 (2020) Catharine Morgan ; Ruth E. Costello ; David W. Ray ; William G. DixonHow Do Glucocorticoids Used in Rheumatic Disease Affect Body Weight? A Narrative Review of the Evidence
000361 (2020) Kunihiko Umekita ; Akihiko OkayamaHTLV-1 Infection and Rheumatic Diseases
000372 (2020) Michie Imamura ; Akihiro Mukaino ; Koutaro Takamatsu ; Hiroto Tsuboi ; Osamu Higuchi ; Hideki Nakamura ; Saori Abe ; Yukio Ando ; Hidenori Matsuo ; Tadashi Nakamura ; Takayuki Sumida ; Atsushi Kawakami ; Shunya NakaneGanglionic Acetylcholine Receptor Antibodies and Autonomic Dysfunction in Autoimmune Rheumatic Diseases
000395 (2020) Mohsen Jari [Iran] ; Reza Shiari [Iran] ; Omid Salehpour [Iran] ; Khosro Rahmani [Iran]Epidemiological and advanced therapeutic approaches to treatment of uveitis in pediatric rheumatic diseases: a systematic review and meta-analysis
000434 (2020) Rahime Koç [Turquie] ; Hafize Emine Sönmez [Turquie] ; Mustafa Çakan [Turquie] ; Erife Gül Karada [Turquie] ; Ay E Tanatar [Turquie] ; Figen Çakmak [Turquie] ; Nuray Aktay Ayaz [Turquie]Drug reactions in children with rheumatic diseases receiving parenteral therapies: 9 years' experience of a tertiary pediatric rheumatology center.
000459 (2020) Benjamin Birkner [Allemagne] ; Jürgen Rech [Allemagne] ; Tom Stargardt [Allemagne]Cost-utility analysis of de-escalating biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
000466 (2020) Tsvetoslav GeorgievCoronavirus disease 2019 (COVID-19) and anti-rheumatic drugs
000473 (2020) Konstantinos Thomas [Grèce] ; Emilia Hadziyannis [Grèce] ; Chrisoula Hatzara [Grèce] ; Anastasia Makris [Grèce] ; Christina Tsalapaki [Grèce] ; Argyro Lazarini [Grèce] ; Kalliopi Klavdianou [Grèce] ; Katerina Antonatou [Grèce] ; Christos Koutsianas [Grèce] ; Dimitrios Vassilopoulos [Grèce]Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic Treatment
000514 (2020) Fatih Ha Lak [Turquie] ; Mehmet Y Ld Z [Turquie] ; Amra Adrovic [Turquie] ; Kenan Barut [Turquie] ; Özgür Kasapçopur [Turquie]Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon
000571 (2020) Seong-Kyu Kim ; Sang Gyu Kwak [Corée du Sud] ; Jung-Yoon ChoeAssociation between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "rheumatic" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "rheumatic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    rheumatic
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021